We are live on ! Find out more
SCM

Scopia Capital Management Portfolio holdings

AUM $112M Turnover 21.74%
1-Year Est. Return 48.41%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+48.41%
3 Year Est. Return
+58.7%
5 Year Est. Return
+80.15%
10 Year Est. Return
+533.22%
AUM
$5.2B
AUM Growth
-$526M
Cap. Flow
-$267M
Cap. Flow %
-5.14%
Top 10 Hldgs %
61.55%
Holding
40
New
2
Increased
12
Reduced
16
Closed
2
Avg Time Held Equity + Options
1.2 years
Top 10 Avg Time Held Equity + Options
1.5 years
Top 20 Avg Time Held Equity + Options
1.7 years
Avg Time Held Equity only
1.3 years
Top 10 Avg Time Held Equity only
1.9 years
Top 20 Avg Time Held Equity only
1.7 years

Sector Composition

Rank Sector Weight
1 Healthcare 32%
2 Industrials 15.06%
3 Real Estate 13.9%
4 Technology 11.45%
5 Miscellaneous 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PRTA icon
26
Prothena Corp
PRTA
$436M
$51.2M 0.99%
3,916,407
+405,523
+12% +$5.86M
2018 Q2
1 quarter
YMAB icon
27
DELISTED
Y-mAbs Therapeutics
YMAB
$42.2M 0.81%
+1,587,566
New +$40.4M
2018 Q3
0 quarters
AYI icon
28
Acuity Brands
AYI
$9.04B
$29.2M 0.56%
185,930
– –
2018 Q1
2 quarters
SMTA
29
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
$27.8M 0.53%
2,410,153
-2,903
-0.1% -$30.9K
2018 Q2
1 quarter
PAGP icon
30
Plains GP Holdings
PAGP
$5.38B
$25.9M 0.5%
1,055,000
-2,761,582
-72% -$68.4M
2017 Q3
4 quarters
CVON
31
DELISTED
ConvergeOne Holdings, Inc. Class A Common Stock
CVON
$14.4M 0.28%
1,551,828
-472,525
-23% -$4.42M
2018 Q2
1 quarter
FOSL icon
32
Fossil Group
FOSL
$407M
$9.22M 0.18%
395,925
– –
2018 Q1
2 quarters
ICPT
33
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$8.21M 0.16%
64,961
– –
2018 Q1
2 quarters
SAFM
34
DELISTED
Sanderson Farms Inc
SAFM
$7.95M 0.15%
76,887
– –
2018 Q1
2 quarters
IFRX icon
35
InflaRx
IFRX
$212M
$7.04M 0.14%
+205,080
New +$6.61M
2018 Q3
0 quarters
MNKD icon
36
MannKind Corp
MNKD
$1.03B
$3.05M 0.06%
1,666,498
– –
2018 Q1
2 quarters
AMSC icon
37
American Superconductor
AMSC
$1.3B
$136K ﹤0.01%
19,610
– –
2018 Q1
2 quarters
OPTU icon
38
Optimum Communications Inc
OPTU
$366M
– –
-10,074,693
Closed -$172M –
BIDU icon
39
Baidu
BIDU
$28.1B
– –
-507,893
Closed -$123M –

Similar funds

Scopia Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Scopia Capital Management held 40 positions worth $5.2B, down 9.2% from $5.72B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Scopia Capital Management withdrew a net $267M in Q3 2018, closing 2 positions and reducing 16 holdings. Its most notable exit was Optimum Communications Inc, an estimated $172M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Industrials and Real Estate.

Against the trend, Scopia Capital Management opened a new position in Y-mAbs Therapeutics worth $42.2M.

  • Scopia Capital Management's largest Q3 2018 buy was Y-mAbs Therapeutics: 1,587,566 shares worth $42.2M.
  • Scopia Capital Management added most to ARRIS International plc Ordinary Shares in Q3 2018, an estimated $125M increase.
  • Scopia Capital Management's biggest Q3 2018 reduction was Wayfair, cutting an estimated $156M.
  • Scopia Capital Management fully exited Optimum Communications Inc in Q3 2018, selling an estimated $172M.
  • Scopia Capital Management's ten largest holdings make up 62% of its $5.2B portfolio in Q3 2018.
  • Scopia Capital Management opened 2 new positions and closed 2 in Q3 2018.
  • Scopia Capital Management's portfolio value fell 9.2% quarter-over-quarter to $5.2B.

Based on Scopia Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.